Cervical cancer: open trials in Switzerland

3 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Inselspital Bern - Universitätsklinik für Medizinische Onkologie, Bern · Hopitaux Universitaires de Geneve - Oncology Department, Geneva · UniversitätsSpital Zürich (USZ) - Klinik für Medizinische Onkologie und Hämatologie, Zurich
Registry updated 2026-11-04
NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Trial Treatment · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
Kantonsspital Graubunden, Chur · University Hospital Lausanne, CHUV, Lausanne · CHUV - Service de pharmacie BH-04, Essais cliniques, Lausanne
Registry updated 2026-07-06
NCT07171658
Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
Trial Treatment · Jessica Di Vincenzo Sormani
University Hospitals of Geneva, Geneva
Registry updated 2025-12-22

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)